The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure